Join Drs. Victoria Werth and Teri Greiling as they explain the autoimmunity driving bullous pemphigoid (BP), as well as the important role type 2 inflammation plays in BP.
Join Dr. Teri Greiling as she discusses the heterogeneous clinical presentations seen in bullous pemphigoid (BP). She also shares diagnostic challenges, including the unclear epidemiology and the extensive differential diagnoses faced by patients with BP.
Join Dr. Victoria Werth as she shares the unmet needs and management challenges experienced by patients with bullous pemphigoid (BP), including physical, mental, socioeconomic, and treatment-related burdens. She expands on the comorbidities and increased mortality rates these patients may face.
Watch Dr. Donna Culton and Prof. Ulrike Raap at EADV 2025 as they explore the clinical presentation and diagnosis of BP and break down the underlying pathophysiology including the roles of autoimmunity and key inflammatory pathways such as Type 2 inflammation.
Experience this engaging presentation by Dr. Donna Culton, Prof. Dédée Murrell, and Prof. Ulrike Raap, who highlight the heterogeneous clinical presentations of BP and its burden, delve beneath the surface into how autoimmunity and predominantly type 2 inflammation mediate the disease, and explore the evolving toolbox of current approaches in BP management.

Welcome to the BP learning hub focused on key scientific education on bullous pemphigoid, featuring ADVENT resources.
Professor Joost Meijer discusses the complex etiology and diagnosis of BP
Professor Enno Schmidt discusses the pathophysiology of BP, focusing on the role of type 2 inflammation and blister formation

Join Dr. Werth as she outlines how early diagnosis and treatment are critical to minimize risk and improve long term outcomes in patients with BP.
Dr. Donna Culton focuses on the challenges of diagnosis and the unmet needs for patients with BP

Dr. Victoria Werth walks through the serious comorbidity risks associated with BP diagnosis

Join Dr. Victoria Werth in exploring the clinical presentation of BP and how type 2 inflammation contributes to the development of disease signs and symptoms